| View |
|
DRP-15150-02
|
Trimetazidine Hydrochloride
|
Pectocard
|
35 mg
|
Film-Coated Tablet
|
Other Cardiac Preparation
|
PSA Chemicals & Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
29 September 2024
|
14 May 2029
|
| View |
|
DRP-15204-01
|
Enalapril maleate
|
Retanapril
|
5 mg
|
Tablet
|
Angiotensin-converting Enzyme (ACE) Inhibitor
|
S Kant Healthcare Ltd.
|
India
|
CLIDP Conversion
|
24 September 2024
|
24 May 2029
|
| View |
|
DRP-15054-02
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
I-Bactam-1.5
|
1g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin-Beta-lactamase Inhibitor Combination)
|
Med Biopharm Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
04 August 2028
|
| View |
|
DRP-15193-01
|
Pantoprazole (as sodium sesquihydrate) + Domperidone
|
Duox
|
40 mg/30 mg
|
Modified Release Capsule
|
Proton Pump Inhibitor/Prokinetic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
24 May 2029
|
| View |
|
DRP-15342-01
|
Dapagliflozin (as propanediol monohydrate)
|
Catania
|
10 mg
|
Film-Coated Tablet
|
Sodium-Glucose Co-Transporter 2(SGLT2) Inhibitor
|
Baroque Pharmaceuticals Private Limited
|
India
|
CLIDP Conversion
|
15 September 2024
|
25 June 2029
|
| View |
|
DRP-15107-03
|
Gliclazide
|
Diaglez-60
|
60 mg
|
Modified-Release Tablet
|
Blood Glucose Lowering (Sulfonylureas)
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2024
|
20 December 2028
|
| View |
|
DRP-15726
|
Dapagliflozin
|
Dapafast
|
10 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug [Sodium-Glucose Co- Transporter 2 (SGLT2) Inhibitor]
|
Fluorish Pharma
|
India
|
Initial
|
10 September 2024
|
10 September 2029
|
| View |
|
DR-XY49197
|
Docetaxel
|
Kintax
|
80 mg/ 8 mL (10 mg/mL)
|
Solution for IV Infusion
|
Antineoplastic (Taxane)
|
Kindos Pharmaceutical Co., Ltd.
|
China
|
Initial
|
10 September 2024
|
10 September 2029
|
| View |
|
DR-XY49198
|
Docetaxel
|
Kintax
|
20 mg/ 2 mL (10 mg/mL)
|
Solution for IV Infusion
|
Antineoplastic (Taxane)
|
Kindos Pharmaceutical Co., Ltd.
|
China
|
Initial
|
10 September 2024
|
10 September 2029
|
| View |
|
DRP-15759
|
Eperisone hydrochloride
|
Reduspasm
|
50 mg
|
Film-Coated Tablet
|
Muscle Relaxant
|
Magbro Healthcare Pvt. Ltd.
|
India
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15749
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Amtacil
|
1 g/500 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Beta-lactam Antibacterial
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
Initial
|
10 September 2024
|
10 September 2029
|
| View |
|
DRP-15740
|
Aripiprazole
|
Ariprazol
|
15 mg
|
Tablet
|
Antipsychotic
|
Limited Liability Company "Pharma Start"
|
Ukraine
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15741
|
Aripiprazole
|
Ariprazol
|
10 mg
|
Tablet
|
Antipsychotic
|
Limited Liability Company "Pharma Start"
|
Ukraine
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15763
|
Cefuroxime (as sodium)
|
Furimax-750
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosphorin).
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15745
|
Pregabalin
|
Nervilor 150
|
150mg
|
Capsule
|
Anti-Epileptic
|
Kopran Limited
|
India
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15746
|
Pregabalin
|
Nervilor 75
|
75 mg
|
Capsule
|
Anti-Epileptic
|
Kopran Limited
|
India
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15761
|
Linagliptin
|
Linesta
|
5 mg
|
Film-Coated Tablet
|
Antidiabetic
|
Hetero Labs Limited (Unit V)
|
India
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DRP-15762
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Pipzo
|
4 g/500 mg
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin + Beta-lactamase Inhibitor)
|
East African (India) Overseas
|
India
|
Initial
|
11 September 2024
|
11 September 2029
|
| View |
|
DR-XY49201
|
Metoprolol tartrate + Ivabradine (s hydrochloride)
|
Ibra Met
|
25 mg/5 mg
|
Film-Coated Tablet
|
Selective beta-blocking Agent/Anti-Angina
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
11 September 2024
|
11 September 2029
|
| View |
|
DR-XY49200
|
Metoprolol tartrate + Ivabradine (s hydrochloride)
|
Ibra Met
|
50 mg/5 mg
|
Film-Coated Tablet
|
Selective beta-blocking Agent/Anti-Angina
|
Ajanta Pharma Limited
|
India
|
Monitored Release
|
11 September 2024
|
11 September 2029
|